Transcutaneous Electrical Nerve Stimulation for Acute Postoperative Pain After Video-Assisted Thoracoscopic Surgery
Effects of Transcutaneous Electrical Nerve Stimulation on Acute Postoperative Pain, Sleep Quality, and Quality of Life in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Randomized, Double-Blind, Sham-Controlled Study
1 other identifier
interventional
90
1 country
1
Brief Summary
This randomized, double-blind, sham-controlled study aims to evaluate the effects of transcutaneous electrical nerve stimulation (TENS) on acute postoperative pain, sleep quality, and quality of life in patients undergoing video-assisted thoracoscopic surgery (VATS). Participants will be randomly assigned to either an active TENS group or a sham TENS group. TENS treatment will be administered twice daily for 30 minutes over three consecutive days beginning 24 hours after surgery. Pain intensity, sleep quality, and quality of life will be assessed at predefined time points to determine the effectiveness of TENS as an adjunctive postoperative pain management strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 28, 2025
CompletedFirst Submitted
Initial submission to the registry
July 17, 2026
CompletedFirst Posted
Study publicly available on registry
July 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
July 29, 2026
July 1, 2026
1.1 years
July 17, 2026
July 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity (Numeric Rating Scale, NRS)
Pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.
Preoperative baseline; 24 hours after initiation of the intervention; 72 hours after initiation of the intervention; and on the day of hospital discharge.
Secondary Outcomes (2)
Sleep quality (Richards-Campbell Sleep Questionnaire, RCSQ)
Preoperative baseline; 24 hours after initiation of the intervention; 72 hours after initiation of the intervention; and on the day of hospital discharge.
Health-related quality of life (PROMIS Global Health Scale)
Preoperative baseline; 24 hours after initiation of the intervention; 72 hours after initiation of the intervention; and on the day of hospital discharge.
Study Arms (2)
Active TENS
EXPERIMENTALParticipants receive active transcutaneous electrical nerve stimulation (TENS) in addition to standard postoperative care. TENS is applied around the surgical site using four electrodes at 100 Hz and a pulse width of 200 microseconds for 30 minutes twice daily for three consecutive days.
Sham TENS
SHAM COMPARATORParticipants receive sham transcutaneous electrical nerve stimulation (TENS) using identical electrode placement and treatment procedures as the active TENS group, but without therapeutic electrical stimulation. Sessions last 30 minutes twice daily for three consecutive days
Interventions
Active transcutaneous electrical nerve stimulation (TENS) is administered in addition to standard postoperative care. Four electrodes are placed around the surgical site. Electrical stimulation is delivered at a frequency of 100 Hz with a pulse width of 200 microseconds for 30 minutes per session, twice daily for three consecutive days. The stimulation intensity is adjusted to the highest level tolerated without discomfort.
Sham transcutaneous electrical nerve stimulation (TENS) uses identical electrode placement and treatment procedures as the active TENS intervention but delivers no therapeutic electrical stimulation. Participants continue to receive standard postoperative care.
Eligibility Criteria
You may qualify if:
- Aged 15 to 85 years.
- Participants younger than 18 years of age must have written informed consent provided by a parent or legal guardian.
- Able to communicate and read/write in Chinese.
- Scheduled to undergo video-assisted thoracoscopic surgery (VATS) as determined by the treating physician.
- Have stable vital signs.
- Willing to participate in the study and able to complete all study procedures.
You may not qualify if:
- History of a bleeding disorder.
- Patients undergoing emergency surgery.
- Patients undergoing bilateral video-assisted thoracoscopic surgery (VATS).
- History of cardiac disease, including cardiac arrhythmia or implantation of a cardiac pacemaker.
- Known allergy or hypersensitivity to TENS electrodes or adhesive pads.
- Cognitive impairment or inability to comply with the study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yuan's General Hospital
Kaohsiung City, Kaohsiung City, 806, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hui-Fang Yeh, phD
Fooyin University
- PRINCIPAL INVESTIGATOR
JIA-XIN LIN, NP
Fooyin University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors are blinded to treatment assignment. Participants in the sham TENS group receive identical electrode placement and procedures without therapeutic electrical stimulation to maintain blinding.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2026
First Posted
July 29, 2026
Study Start
August 28, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
July 29, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) collected during this study will not be made publicly available. There is no current plan to share de-identified individual participant data with other researchers.